The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600
| Autor: | Massi, D., Brusa, D., Merelli, B., Falcone, C., Xue, G., Carobbio, A., Nassini, R., Baroni, G., Tamborini, E., Cattaneo, L., Audrito, V., Deaglio, S., Mandalà, M. * |
|---|---|
| Zdroj: | In Annals of Oncology September 2015 26(9):1980-1987 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|